CLINICAL INVESTIGATION OF AUTOLOGOUS T CELLS TARGETED TO PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) FOR THE TREATMENT OF CASTRATE METASTATIC PROSTATE

$1,407,409FY2009Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators